Amylyx Pharmaceuticals Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Amylyx Pharmaceuticals (AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
March 30, 2022 4:51 PM EDT(Updated - March 30, 2022 4:51 PM EDT)
Amylyx Pharmaceuticals (NASDAQ: AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
... MoreAmylyx Pharmaceuticals (AMLX) Confirms Shares Halted Ahead of FDA Advisory Committee Meeting to Discuss NDA for AMX0035 for the Treatment of ALS
March 30, 2022 7:07 AM EDTAmylyx Pharmaceuticals (NASDAQ: AMLX) today announced that Nasdaq has halted trading of the companys common stock.
The U.S. Food and Drug Administrations (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) is meeting today to review the New Drug Application... More
